These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30072997)

  • 1. Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
    Scheuerlein P; Pietsch L; Camacho-Ordonez N; Reiser V; Patel S; Burns SO; Warnatz K; Grimbacher B
    Front Immunol; 2018; 9():1656. PubMed ID: 30072997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.
    Michel M; Chanet V; Galicier L; Ruivard M; Levy Y; Hermine O; Oksenhendler E; Schaeffer A; Bierling P; Godeau B
    Medicine (Baltimore); 2004 Jul; 83(4):254-263. PubMed ID: 15232313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
    Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients.
    Danieli MG; Verga JU; Mezzanotte C; Terrenato I; Svegliati S; Bilo MB; Moroncini G
    Front Immunol; 2021; 12():805705. PubMed ID: 35111165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
    Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
    Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.
    Ameratunga R; Woon ST; Gillis D; Koopmans W; Steele R
    Clin Exp Immunol; 2013 Nov; 174(2):203-11. PubMed ID: 23859429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
    Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
    An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcomes on subcutaneous IgG in patients with humoral immunodeficiency and co-morbid bowel disease.
    Shah SN; Todoric K; Tarrant TK
    Clin Case Rep Rev; 2015 Jul; 1(7):151-152. PubMed ID: 27042340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study.
    Ameratunga R; Longhurst H; Steele R; Woon ST
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):236-244. PubMed ID: 34236581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia.
    Fischer P; Jendreyko N; Hoffmann M; Lerch H; Uttenreuther-Fischer MM; Chen PP; Gaedicke G
    Br J Haematol; 1999 Jun; 105(3):626-40. PubMed ID: 10354123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease.
    Arora R; Newton TC; Nelson MR
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):367-70. PubMed ID: 17941286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
    Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
    Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.
    Kasztalska K; Ciebiada M; Cebula-Obrzut B; Górski P
    Clin Drug Investig; 2011; 31(5):299-307. PubMed ID: 21473654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
    Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B
    Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia in common variable immunodeficiency patients - clinical course, management, and effect of immunoglobulins.
    Pituch-Noworolska A; Siedlar M; Kowalczyk D; Szaflarska A; Błaut-Szlósarczyk A; Zwonarz K
    Cent Eur J Immunol; 2015; 40(1):83-90. PubMed ID: 26155188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of subcutaneous immunoglobulin by rapid "push" infusion for primary immunodeficiency patients in Manitoba: a retrospective review.
    Walter G; Kalicinsky C; Warrington R; Miguel M; Reyes J; Rubin TS
    Allergy Asthma Clin Immunol; 2020; 16():34. PubMed ID: 32426003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.